We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
10:30 - 11:10
A1 Plenary
New trials in glioblastoma and primary CNS lymphoma
Felix Ehret, Germany;
Slávka Lukacova, Denmark
Proffered Papers
Clinical
10:30 - 11:10
Final results of a nationwide multicenter randomized trial (GOLD) on hypofractionated chemoradiation for glioblastoma: survival and HRQoL
Anouk de Jong, The Netherlands
-2249
10:30 - 11:10
Dual Inhibition of Post-Radiogenic Revascularization in Newly-Diagnosed Glioblastoma - Final results of the multicentric phase 1/2 GLORIA trial.
Julian Philipp Layer, Germany
-423
10:30 - 11:10
Influence of FLAIR Inclusion on Recurrence Patterns and Outcomes in Glioblastoma: Results from a Prospective Adaptive Radiotherapy Trial (UNITED)
Suman Ghosh, Canada
-3420
10:30 - 11:10
Outcome after low- vs. high-dose whole brain radiotherapy +/- boost in primary CNS lymphoma – results from a comparative multicenter analysis
Clemens Seidel, Germany
-3190